Meson Screening Mass in a Strongly Coupled Pion Superfluid

We calculate the meson screening mass in a pion superfluid in the framework of Nambu--Jona-Lasinio model. The minimum of the attractive quark potential is always located at the phase boundary of pion superfluid. Different from the temperature and baryon density effect, the potential at finite isospin density can not be efficiently suppressed and the matter is always in a strongly coupled phase due to the Goldstone mode in the pion superfluid.Comment: 8 pages, 7 figures(Accepted by European Physical Journal C

Phase structures of strong coupling lattice QCD with finite baryon and isospin density

Quantum chromodynamics (QCD) at finite temperature (T), baryon chemical potential (\muB) and isospin chemical potential (\muI) is studied in the strong coupling limit on a lattice with staggered fermions. With the use of large dimensional expansion and the mean field approximation, we derive an effective action written in terms of the chiral condensate and pion condensate as a function of T, \muB and \muI. The phase structure in the space of T and \muB is elucidated, and simple analytical formulas for the critical line of the chiral phase transition and the tricritical point are derived. The effects of a finite quark mass (m) and finite \muI on the phase diagram are discussed. We also investigate the phase structure in the space of T, \muI and m, and clarify the correspondence between color SU(3) QCD with finite isospin density and color SU(2) QCD with finite baryon density. Comparisons of our results with those from recent Monte Carlo lattice simulations on finite density QCD are given.Comment: 18 pages, 6 figures, revtex4; some discussions are clarified, version to appear in Phys. Rev.

Defining an adipose tissue single cell atlas to understand metabolic disease in HIV

Background: Adipose tissue (AT) is a critical regulator of metabolic health and is emerging as important in HIV. Despite this, data on the complex cellular milieu and immune regulation are lacking. We sought to assess the AT microenvironment in persons with HIV (PWH). Methods: We performed subcutaneous abdominal liposuction and isolated the stromal vascular fraction (SVF) from 16 HIV-negative diabetics, 16 HIV-positive non-diabetics and 16 HIV-positive diabetics on long-term ART. Cells were stained with a panel of 5’ DNA-sequence tagged antibodies (TotalSeq-C) that represented standard lineages, activation and regulatory markers (45 antibodies). For the analysis, CellRanger (version 3.0.0) was used to demultiplex the raw sequencing data, extract filter and correct barcodes and unique molecular identifiers, remove cDNA PCR duplicates and align reads to the human transcriptome (GRCh38). The resulting BAM files and filtered count matrices were used in analyses. We assessed the AT cell types and their association of these subsets with the preadipocytes (Spearman rank correlation). Results: Agnostic to metabolic disease, PWH had lower proportions of pre-adipocytes (median 20.4% in non-diabetic and 36.4% in diabetic) compared with HIV-negative diabetic participants (62.7%) (Figure 1). The proportion of CD8 T cells, monocytes and NK cells were significantly higher in PWH compared with HIV-negative participants, irrespective of metabolic disease. Pre-adipocyte and NK cells were inversely related in non-diabetic PWH (r = _0.68, p = 0.005), diabetic PWH (r = _0.70, p = 0.004) and HIV-negative diabetics (r = _0.51, p = 0.05). A similar trend was observed between CD8 T cells and pre-adipocytes. Conclusions: We have generated a detailed atlas of AT SVF by HIV and diabetes status and show that PWH have higher proportions of NK and T cells compared with diabetic HIV negative. We hypothesize that this may correlate with the HIV reservoir. Future studies will pair this data with measurements of the HIV reservoir quantification and ART drug levels to understand how AT contributes to viral persistence